本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ADC Therapeutics SA

3.20
+0.15004.92%
盘后3.200.00000.00%16:04 EDT
成交量:46.06万
成交额:145.26万
市值:3.58亿
市盈率:-2.21
高:3.22
开:3.10
低:3.03
收:3.05
数据加载中...
2023/12/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/04/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/21

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/16

SEC问询函

Form CORRESP - Correspondence
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/02

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/12/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals